These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Effect of risk classification on the indications for gynecologic surgery]. Majewski A; Börner P; Böhme U; Zimmermann P Arch Gynecol; 1979 Jul; 228(1-4):276-7. PubMed ID: 485335 [No Abstract] [Full Text] [Related]
24. Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer. Eldor L; Spiegel A Breast J; 2009; 15 Suppl 1():S81-9. PubMed ID: 19775335 [TBL] [Abstract][Full Text] [Related]
25. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Forman AD; Hall MJ Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331 [TBL] [Abstract][Full Text] [Related]
26. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part II). Lynch HT; Snyder CL; Lynch JF Breast J; 2009; 15 Suppl 1():S11-9. PubMed ID: 19775324 [TBL] [Abstract][Full Text] [Related]
27. Controversies in communication of genetic risk for hereditary breast cancer. Mackenzie A; Patrick-Miller L; Bradbury AR Breast J; 2009; 15 Suppl 1():S25-32. PubMed ID: 19775327 [TBL] [Abstract][Full Text] [Related]
28. Surgical prophylaxis for inheritable malignant diseases: breast cancer and endocrine disease. Benns MV; Luk T; Scoggins CR Am Surg; 2009 Jul; 75(7):529-36. PubMed ID: 19655594 [TBL] [Abstract][Full Text] [Related]
29. Polygenes, risk prediction, and targeted prevention of breast cancer. Teixeira L; Julien C; Guimiot F N Engl J Med; 2008 Sep; 359(13):1406-7. PubMed ID: 18822456 [No Abstract] [Full Text] [Related]
30. [Progestational hormones in the pathogenesis, prophylaxis, and therapy of mammary and genital tumours]. Kaiser R Rev Fr Gynecol Obstet; 1973 Oct; 68(10):549-53. PubMed ID: 17474211 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of breast cancer in patients with gynaecological malignancies. Karjalainen O Ann Chir Gynaecol; 1987; 76(2):87. PubMed ID: 3619393 [No Abstract] [Full Text] [Related]
32. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer. Silva E Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334 [TBL] [Abstract][Full Text] [Related]
33. [Laser surgery. General aspects and gynecological applications]. Massobrio M; Borgno G; Benedetto C Minerva Ginecol; 1981; 33(2-3):213-20. PubMed ID: 7254652 [No Abstract] [Full Text] [Related]
34. Integrative medicine in gynaecological cancers. Sali A; Vitetta L Aust Fam Physician; 2007 Mar; 36(3):135-6. PubMed ID: 17339975 [TBL] [Abstract][Full Text] [Related]
35. [Medical perception of the hereditary aspects of cancer in The Netherlands, 1900-1980]. Wobbes T Ned Tijdschr Geneeskd; 2007 May; 151(18):1045. PubMed ID: 17508695 [No Abstract] [Full Text] [Related]
37. [Genital lichen sclerosus et atrophicans: a precancerous condition?]. Korge B Hautarzt; 2008 Jan; 59(1):77. PubMed ID: 18217174 [No Abstract] [Full Text] [Related]
38. Recent advances in the understanding of reproductive malignancies. A new section. Berkowitz RS J Reprod Med; 2000 Sep; 45(9):691. PubMed ID: 11027077 [No Abstract] [Full Text] [Related]
39. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I). Snyder CL; Lynch JF; Lynch HT Breast J; 2009; 15 Suppl 1():S2-10. PubMed ID: 19775325 [TBL] [Abstract][Full Text] [Related]
40. [The experiences of Arnstadt county in the activation and intensification of gynecologic preventive examinations]. Pleissner K Z Arztl Fortbild (Jena); 1971 Oct; 65(19):1090-3. PubMed ID: 5149987 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]